We believe that no cancer patient should go without the safe and effective treatment they need.

Arrow Down Icon

Virus manufacturing for oncolytic virotherapy

The registration and commercialization for new medication is a highly demanding and technical challenge, considering the development of a reliable and sustainable manufacturing process for production of safe and effective products in compliance with global regulatory requirements.

Our manufacturing is according to GMP (Good Manufacturing Practice regulations). A new facility of biotechnological manufacturing with increased capacity, diversified R&D capabilities and exceptional know-how to produce the high-quality oncolytic ECHO-7 virus is certified in June 2020.




Reliable production of consistent oncotropic, non-pathogenic virus.

Disease – specific oncolytic virotherapy development.